Search all trials

Find therapies in clinical trials near you – page 28

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Prostate cancer metastatic

Not recruiting

Registered drug

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ceritinib

Contact Research Centre

Asthma

Not recruiting

Registered drug

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Non-small cell lung cancer+4

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Osimertinib

Contact Research Centre

Glomerulonephritis membranous

Not recruiting

Registered drugNo placebo

Study of Felzartamab for Patients with Membranous Nephropathy Resistant to Anti-CD20 Therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Aminohippuric Acid

Contact Research Centre

Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

Not recruiting

InvestigationalNo placebo

Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Givinostat

Contact Research Centre

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Not recruiting

Registered drugNo placebo

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Tofacitinib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cevostamab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Bortezomib

Contact Research Centre

Find therapies in clinical trials near you – page 28

375 trials match your criteria

Prostate cancer metastatic

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Non-small cell lung cancer

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer

Asthma

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Non-small cell lung cancer+4

Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

Glomerulonephritis membranous

Study of Felzartamab for Patients with Membranous Nephropathy Resistant to Anti-CD20 Therapy

Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Colitis ulcerative

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Plasma cell myeloma

Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Plasma cell myeloma

Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.